Search for conditions to avoid parametrectomy during radical hysterectomy for cervical cancer.


Journal

The journal of obstetrics and gynaecology research
ISSN: 1447-0756
Titre abrégé: J Obstet Gynaecol Res
Pays: Australia
ID NLM: 9612761

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 27 09 2018
accepted: 11 04 2019
pubmed: 21 5 2019
medline: 15 1 2020
entrez: 21 5 2019
Statut: ppublish

Résumé

This study aimed to assess adequate conditions for omitting parametrectomy for stage IB1-IIA2 cervical cancer with the aim of reducing postoperative complications during Type III radical hysterectomy (RH). We investigated factors associated with parametrial invasion (PMI) in patients who underwent Type III RH for stage IB1, IB2, IIA1, IIA2 and IIB cervical cancer at two tertiary institutions from November 2006 to February 2018. Both clinicopathological and preoperatively estimated factors were assessed. One hundred fifty-six patients were preoperatively diagnosed with stage IB1 to IIB disease. Thirty-four patients (21.8%) showed PMI on histological analyses. In the multivariate analysis, an age older than 50 years, tumor size larger than 40 mm, common iliac lymph node metastasis and lymphovascular space invasion were identified as significant risk factors for PMI (P-values = 0.008, 0.003, 0.004 and 0.004, respectively). The preoperatively estimated risk factors for PMI were an older age, larger tumor size, and common iliac lymph node metastasis (P-values = 0.007, 0.002 and 0.001, respectively). A combination of these three factors was sufficient to estimate PMI with a high specificity (100%) and positive predictive value (100%) in patients with stage IB1 to IIA2 disease. During RH, resecting the posterior layer of the vesicouterine ligament and the paracolpium without removing the cardinal ligament (avoiding parametrectomy) might be feasible for stage IB1-IIA2 cervical cancer in patients younger than 50 years presenting with smaller tumors (<40 mm) and no common iliac lymph node metastasis.

Identifiants

pubmed: 31106933
doi: 10.1111/jog.13986
pmc: PMC6617803
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1371-1375

Informations de copyright

© 2019 The Authors. Journal of Obstetrics and Gynaecology Research published by John Wiley & Sons Australia, Ltd on behalf of Japan Society of Obstetrics and Gynecology.

Références

Gynecol Oncol. 2012 Jul;126(1):82-6
pubmed: 22516661
Aust N Z J Obstet Gynaecol. 2012 Dec;52(6):540-4
pubmed: 23216324
Int J Gynecol Cancer. 2014 Sep;24(7):1333-40
pubmed: 25078340
J Med Life. 2014 Jun 15;7(2):172-6
pubmed: 25408722
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Int J Clin Oncol. 2015 Apr;20(2):240-8
pubmed: 25800808
J Gynecol Oncol. 2015 Oct;26(4):255-61
pubmed: 26197769
Int J Gynecol Cancer. 2016 Jan;26(1):184-91
pubmed: 26512782
Int J Gynecol Cancer. 2016 Jun;26(5):939-43
pubmed: 26905336
Int J Gynecol Cancer. 2017 Feb;27(2):332-338
pubmed: 28114236
Int J Gynecol Cancer. 2017 Mar;27(3):507-513
pubmed: 28129242
Gynecol Oncol. 2017 Jul;146(1):16-19
pubmed: 28392128
Int J Gynecol Cancer. 2017 Oct;27(8):1722-1728
pubmed: 28617687
Baillieres Clin Obstet Gynaecol. 1997 Mar;11(1):149-66
pubmed: 9155941

Auteurs

Fuminori Ito (F)

Department of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara, Japan.

Atsushi Sugiura (A)

Department of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara, Japan.

Shinji Toyoda (S)

Department of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara, Japan.

Yoshio Itani (Y)

Department of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara, Japan.

Kana Iwai (K)

Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Japan.

Yuki Yamada (Y)

Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Japan.

Yasuhito Tanase (Y)

Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Japan.

Ryuji Kawaguchi (R)

Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Japan.

Hiroshi Kobayashi (H)

Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Japan.

Tsunekazu Kita (T)

Department of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH